PGC-1α expression was closely related to prognosis (relative risk = 0.177, 95% CI, 0.075–0.417, p < 0.001), highlighting its potential as a critical prognostic factor in glioma. This evidence concerns the gene PPARGC1A and central nervous system cancer.